A groundbreaking technological innovation maintaining a consistent temperature of 18 ºC
After an extensive decade-long journey of experimenting with nearly a thousand different raw materials and dedicating immense resources to the development of revolutionary constant temperature technology, Qingdao Dmd Medical Technology Co., Ltd. has achieved a monumental breakthrough. This pioneering achievement has led to the creation of remarkable products such as constant temperature ice bags, insulin storage cups, constant temperature hot compress bags, and constant temperature eye bags, all engineered to sustain temperatures ranging from -20 ° C to -50 ° C. Some of these cutting-edge technologies are already being implemented within the industry, marking a new era of innovation.
When it comes to managing a common cold and fever in children, especially when their body temperature does not rise above 38.5 ºC, physicians generally advise the use of physical cooling techniques. Traditional methods like applying a cold towel or gently wiping specific areas with warm water, such as the back and armpits, are commonly suggested. However, many parents find it challenging to properly execute these scientific cooling methods effectively.
Baby skin is particularly delicate and may risk frostbite at temperatures below 10 ºC. At a range of 10-15 ºC, the skin might experience stinging and discomfort. A consistent temperature of 18 ºC is deemed the optimal physical cooling measure. In hospital intensive care units, this is the standard setting for brain protection equipment, ensuring a safe and effective cooling process.
Back in 1987, Busto introduced the transformative concept of mild hypothermia brain protection, which is defined by maintaining a body surface temperature between 30 ºC and 35 ºC, with external cold compress devices set to 18 ºC -20 ºC. This innovation has reignited medical interest in low-temperature therapy. Today, in clinical applications, advanced brain cooling devices are utilized to manage intracranial pressure, reduce brain edema, safeguard damaged neurons, and alleviate the complications and aftereffects of ischemic hypoxic encephalopathy, highlighting the remarkable potential of this therapeutic approach.
Audited Supplier 
){kind=link}